Epigenetic inactivation of TRAIL decoy receptors at 8p12‐21.3 commonly deleted region confers sensitivity to Apo2L/trail‐Cisplatin combination therapy in cervical cancer
暂无分享,去创建一个
M. Mansukhani | A. Kaufmann | V. Murty | A. Schneider | Dongxu Xie | B. Pothuri | L. Scotto | G. Narayan | G. Ishdorj | H. Arias-Pulido | J. Wright